Korea Investment CORP Invests $21.74 Million in The Allstate Corporation $ALL

Posted by Geri Gentry on Aug 24th, 2026

Korea Investment CORP purchased a new position in The Allstate Corporation (NYSE:ALL – Free Report) during the second quarter, Holdings Channel reports. The institutional investor purchased 91,375 shares of the insurance provider’s stock, valued at approximately $21,742,000.

Other institutional investors also recently modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Allstate by 5.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 552,120 shares of the insurance provider’s stock valued at $112,533,000 after purchasing an additional 26,586 shares during the period. Strategic Global Advisors LLC grew its stake in Allstate by 19.2% during the fourth quarter. Strategic Global Advisors LLC now owns 48,882 shares of the insurance provider’s stock worth $10,175,000 after purchasing an additional 7,870 shares during the period. Elevation Point Wealth Partners LLC increased its holdings in Allstate by 130.9% in the first quarter. Elevation Point Wealth Partners LLC now owns 19,288 shares of the insurance provider’s stock worth $4,016,000 after purchasing an additional 10,936 shares in the last quarter. CIBC Asset Management Inc increased its holdings in Allstate by 69.2% in the fourth quarter. CIBC Asset Management Inc now owns 63,011 shares of the insurance provider’s stock worth $13,116,000 after purchasing an additional 25,764 shares in the last quarter. Finally, Bank of America Corp DE lifted its stake in Allstate by 8.1% in the first quarter. Bank of America Corp DE now owns 7,913,320 shares of the insurance provider’s stock valued at $1,640,748,000 after buying an additional 596,321 shares during the period. 76.47% of the stock is owned by institutional investors.

Insider Activity at Allstate

In related news, Director Andrea Redmond sold 2,225 shares of Allstate stock in a transaction on Monday, June 1st. The shares were sold at an average price of $202.91, for a total value of $451,474.75. Following the completion of the sale, the director owned 2,225 shares of the company’s stock, valued at approximately $451,474.75. This trade represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Mario Rizzo sold 56,225 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total transaction of $14,870,388.00. Following the sale, the chief operating officer owned 82,227 shares of the company’s stock, valued at $21,747,396.96. This trade represents a 40.61% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 91,446 shares of company stock valued at $24,208,675. 1.55% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on ALL. Weiss Ratings upgraded Allstate from a “buy (a-)” rating to a “buy (a)” rating in a report on Thursday, August 6th. Evercore set a $240.00 price objective on shares of Allstate in a research note on Friday, July 10th. Barclays boosted their target price on shares of Allstate from $213.00 to $226.00 and gave the company an “underweight” rating in a research report on Thursday, August 6th. Atlantic Securities set a $319.00 target price on shares of Allstate in a research note on Wednesday, July 15th. Finally, Roth Capital set a $300.00 price target on shares of Allstate in a report on Thursday, August 6th. Four equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, eight have assigned a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $265.26.

Get Our Latest Report on Allstate

Allstate Stock Down 0.0%

Shares of NYSE:ALL opened at $253.82 on Monday. The business’s 50 day simple moving average is $250.34 and its two-hundred day simple moving average is $225.12. The firm has a market cap of $64.18 billion, a P/E ratio of 5.07, a PEG ratio of 0.39 and a beta of 0.16. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.36 and a current ratio of 0.36. The Allstate Corporation has a 52-week low of $188.08 and a 52-week high of $277.22.

Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, beating analysts’ consensus estimates of $6.06 by $2.93. The firm had revenue of $18.60 billion during the quarter, compared to analysts’ expectations of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%.The company’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same quarter last year, the firm posted $5.94 earnings per share. As a group, research analysts forecast that The Allstate Corporation will post 34.45 EPS for the current fiscal year.

Allstate Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, August 31st will be issued a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Monday, August 31st. Allstate’s dividend payout ratio (DPR) is currently 8.63%.

Allstate News Roundup

Here are the key news stories impacting Allstate this week:

Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Allstate Profile

(Free Report)

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.